Experimental vaccines against measles in a world of changing epidemiology.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International Journal of Parasitology

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0020-7519(03)00062-6PMID 12782053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunogenic measles antigens expressed in plants: role as an edible vaccine for adults.

  2003cited by this paper
• Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-derived measles virus hemagglutinin

  2003cited by this paper
• Neutralising immunogenicity of a polyepitope antigen expressed in a transgenic food plant: a novel antigen to protect against measles.

  2003cited by this paper
• The rationale of a peptide-conjugate vaccine against measles.

  2003cited by this paper
• Functional fine-mapping and molecular modeling of a conserved loop epitope of the measles virus hemagglutinin protein.

  2003cited by this paper
• Molecular Epidemiology in Measles Control

  2002cited by this paper
• A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism

  2002cited by this paper
• Successful Boosting of a DNA Measles Immunization with an Oral Plant-Derived Measles Virus Vaccine

  2002cited by this paper
• A population-based study of measles, mumps, and rubella vaccination and autism.

  2002cited by this paper
• Enteric administration of a live attenuated measles vaccine does not induce protective immunity in a macaque model.

  2002cited by this paper
• Detection of measles vaccine in the throat of a vaccinated child.

  2002cited by this paper
• The Molecular Epidemiology of Human Viruses

  2002cited by this paper
• A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.

  2002cited by this paper
• A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease

  2002cited by this paper
• Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles.

  2002cited by this paper
• Effective synthetic peptide vaccine for foot-and-mouth disease in swine.

  2002cited by this paper
• Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.

  2002cited by this paper
• Priming of measles virus-specific humoral- and cellular-immune responses in macaques by DNA vaccination.

  2002cited by this paper
• Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates.

  2002cited by this paper
• First 5 years of measles elimination in southern Africa: 1996-2000.

  2002cited by this paper
• Vaccination against measles: a neverending story

  2002cited by this paper
• A Chimeric Human-Bovine Parainfluenza Virus Type 3 Expressing Measles Virus Hemagglutinin Is Attenuated for Replication but Is Still Immunogenic in Rhesus Monkeys

  2001cited by this paper
• Measles elimination: old and new challenges?

  2001cited by this paper
• Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.

  2001cited by this paper
• C3d enhancement of neutralizing antibodies to measles hemagglutinin.

  2001cited by this paper
• Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model.

  2001cited by this paper
• Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice.

  2001cited by this paper
• A powder formulation of measles vaccine for aerosol delivery.

  2001cited by this paper
• Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vector.

  2001cited by this paper
• New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules.

  2001cited by this paper
• Approaches to Development of Microencapsulated Form of the Live Measles Vaccine

  2001cited by this paper
• Immunopathogenesis of vaccine-enhanced RSV disease.

  2001cited by this paper
• Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).

  2001cited by this paper
• MVA: a cuckoo in the vaccine nest?

  2001cited by this paper
• Measles in a Dutch hospital introduced by an immuno-compromised infant from Indonesia infected with a new virus genotype.

  2000cited by this paper
• Virus Entry Is a Major Determinant of Cell Tropism of Edmonston and Wild-Type Strains of Measles Virus as Revealed by Vesicular Stomatitis Virus Pseudotypes Bearing Their Envelope Proteins

  2000cited by this paper
• Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review.

  2000cited by this paper
• Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection.

  2000cited by this paper
• Use of cotton rats for preclinical evaluation of measles vaccines.

  2000cited by this paper
• DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection.

  2000cited by this paper
• Successful Vaccine-Induced Seroconversion by Single-Dose Immunization in the Presence of Measles Virus-Specific Maternal Antibodies

  2000cited by this paper
• Human Parainfluenza Virus Type 3 (PIV3) Expressing the Hemagglutinin Protein of Measles Virus Provides a Potential Method for Immunization against Measles Virus and PIV3 in Early Infancy

  2000cited by this paper
• Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.

  2000cited by this paper
• Resistance of recent measles virus wild‐type isolates to antibody‐mediated neutralization by vaccinees with antibody

  2000cited by this paper
• Genetic variability of measles viruses circulating in the Benelux

  2000cited by this paper
• Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.

  2000cited by this paper
• Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.

  2000cited by this paper
• Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes.

  2000cited by this paper
• Use of Cotton Rats to Evaluate the Efficacy of Antivirals in Treatment of Measles Virus Infections

  2000cited by this paper
• Vaccination in the Neonatal Period and Early Infancy

  2000cited by this paper
• Expression of measles virus antigens in Streptococcus gordonii.

  2000cited by this paper
• Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children

  2000cited by this paper
• Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus encephalitis.

  2000cited by this paper
• Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population.

  2000cited by this paper
• Protective Immunity in Macaques Vaccinated with a Modified Vaccinia Virus Ankara-Based Measles Virus Vaccine in the Presence of Passively Acquired Antibodies

  2000cited by this paper
• In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.

  2000cited by this paper
• Differential antigenicity of recombinant polyepitope-antigens based on loop- and helix-forming B and T cell epitopes.

  2000cited by this paper
• Induction of immunity using oral DNA vaccines expressing the measles virus nucleocapsid protein.

  2000cited by this paper
• Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles

  2000cited by this paper
• Measles virus-induced immunosuppression in cotton rats is associated with cell cycle retardation in uninfected lymphocytes.

  1999cited by this paper
• Synthetic peptides as antigens

  1999cited by this paper
• Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity.

  1999cited by this paper
• A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis.

  1999cited by this paper
• Replication of clinical measles virus strains in hispid cotton rats.

  1999cited by this paper
• Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector.

  1999cited by this paper
• Increased Susceptibility to Measles in Infants in the United States

  1999cited by this paper
• Measles vaccines, new developments and immunization strategies.

  1999cited by this paper
• Measles elimination: progress and challenges.

  1999cited by this paper
• Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA.

  1999cited by this paper
• Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.

  1999cited by this paper
• Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage.

  1999cited by this paper
• Seroconversions in unvaccinated infants: further evidence for subclinical measles from vaccine trials in Niakhar, Senegal.

  1999cited by this paper
• Production of atypical measles in rhesus macaques: Evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody

  1999cited by this paper
• Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies.

  1999cited by this paper
• Genotypic and antigenic characterization of hemagglutinin proteins of African measles virus isolates.

  1999cited by this paper
• DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses.

  1999cited by this paper
• Measles Immunization in HIV-Infected Children

  1999cited by this paper
• Altered Virulence of Vaccine Strains of Measles Virus after Prolonged Replication in Human Tissue

  1999cited by this paper
• Implications of the human immunodeficiency virus epidemic for control and eradication of measles.

  1999cited by this paper
• Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains.

  1999cited by this paper
• Dry powder inhalation as a potential delivery method for vaccines.

  1999cited by this paper
• Molecular epidemiology of Nigerian and Ghanaian measles virus isolates reveals a genotype circulating widely in western and central Africa.

  1999cited by this paper
• Measles eradication: experience in the Americas.

  1998cited by this paper
• Total elimination of measles in Finland.

  1998cited by this paper
• Measles Virus DNA Vaccination: Antibody Isotype Is Determined by the Method of Immunization and by the Nature of both the Antigen and the Coimmunized Antigen

  1998cited by this paper
• The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein.

  1998cited by this paper
• Vaccine strategies to overcome maternal antibody mediated inhibition of measles vaccine.

  1998cited by this paper
• Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents.

  1998cited by this paper
• Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.

  1998cited by this paper
• Maternal measles antibody decay in rural Bangladeshi infants--implications for vaccination schedules.

  1998cited by this paper
• A simplified immunoassay based on measles virus recombinant hemagglutinin protein for testing the immune status of vaccinees.

  1998cited by this paper
• Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime‐boost strategies in mice

  1998cited by this paper
• Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen.

  1998cited by this paper
• Enhanced antigenicity of a four-contact-residue epitope of the measles virus hemagglutinin protein by phage display libraries: evidence of a helical structure in the putative active site.

  1998cited by this paper
• Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

  1998cited by this paper
• Immunosorbent Assay Based on Recombinant Hemagglutinin Protein Produced in a High-Efficiency Mammalian Expression System for Surveillance of Measles Immunity

  1998cited by this paper
• Surveillance for waterborne-disease outbreaks--United States, 1995-1996.

  1998cited by this paper
• DNA Vaccination/Genetic Vaccination

  1998cited by this paper
• Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons

  1998cited by this paper
• Placental antibody transfer: influence of maternal HIV infection and placental malaria

  1998cited by this paper

• Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects

  2021cites this paper
• 37 – Measles Vaccines

  2018cites this paper
• Bioactivity of Rosemary and Sage Against Measles

  2015cites this paper
• JournalOfBasicAndApplied---------------------------------------------------------------------------------------------------------------------------Bioactivity of Rosemary and Sage Against Measles

  2015cites this paper
• Synergizing vaccinations with therapeutics for measles eradication

  2014cites this paper
• Toward a New Vaccine Against Measles

  2013cites this paper
• Vaccine Development: History, Current Status, and Future Trends

  2013cites this paper
• 20 – Measles vaccine

  2013cites this paper
• Horizontal transmission and measles vaccine : implications for neo-pathogenesis , measles control , and measles eradication

  2011influential citation
• Cultivation of E. coli carrying a plasmid-based Measles vaccine construct (4.2 kbp pcDNA3F) employing medium optimisation and pH-temperature induction techniques

  2011cites this paper
• Wirus odry – reakcje odpornościowe związane z naturalnym zakażeniem oraz odpowiedzią poszczepienną

  2011cites this paper
• Mucosal adenovirus-vectored vaccine for measles.

  2010cites this paper
• Humoral and Cellular Immune Responses to Measles and Tetanus: The Importance of Elapsed Time Since Last Exposure and the Nature of the Antigen

  2010cites this paper
• A survey on phytochemical and bioactivity of plant extracts from Malaysian forest reserves

  2010cites this paper
• Measles Studies in the Macaque Model

  2009cites this paper
• The role of vaccines in elimination and global eradication of measles: A review of literature

  2009cites this paper
• Measles control--can measles virus inhibitors make a difference?

  2009cites this paper
• Stabilising peptides of a sequential epitope of the Measles Virus Haemagglutinin protein and the implications for antigenicity and immunogenicity

  2009cites this paper
• The Pathogenesis of Measles Revisited

  2008cites this paper
• The pathogenesis of measles revisited

  2008cites this paper
• Rougeole (II). Diagnostic, traitement et prophylaxie

  2007cites this paper
• Validation of a solid‐phase‐bound steroid scaffold for the synthesis of novel cyclic peptidosteroids

  2007cites this paper
• Measles vaccination of macaques by dry powder inhalation.

  2007cites this paper
• Virology Research

  2007influential citation
• Immunogenicity of peptides of measles virus origin and influence of adjuvants.

  2006cites this paper
• Strategy for measles eradication

  2006cites this paper
• Nonpeptide inhibitors of measles virus entry.

  2006cites this paper
• Design of a Small-Molecule Entry Inhibitor with Activity against Primary Measles Virus Strains

  2005cites this paper
• A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali.

  2005cites this paper
• Measles virus-specific antibody levels in Sudanese infants: a prospective study using filter-paper blood samples

  2005cites this paper
• A Meta-Analysis of Studies Comparing the Respiratory Route with the Subcutaneous Route of Measles Vaccine Administration

  2005cites this paper
• A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.

  2005cites this paper
• CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function.

  2004cites this paper
• T Cell Immunity to Measles Viral Proteins in Infants and Adults after Measles Immunization

  2004cites this paper
• Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens.

  2004cites this paper
• A target site for template-based design of measles virus entry inhibitors.

  2004cites this paper
• Modelling measles re-emergence as a result of waning of immunity in vaccinated populations.

  2003cites this paper